HD 5873: A communication from the Executive Office of Health and Human Services (see Section 80 of Chapter 118E of the General Laws) submitting its report on the needs of MassHealth enrollees with a diagnosis of sickle cell disease and the adequacy of available covered medications, treatments and health care services
HD 5873 status: Introduced — Placed on file (updated Aug 17, 2026).
What this bill does
Overall score
Bill summary
OfficialA communication from the Executive Office of Health and Human Services (see Section 80 of Chapter 118E of the General Laws) submitting its report on the needs of MassHealth enrollees with a diagnosis of sickle cell disease and the adequacy of available covered medications, treatments and health care services. Currently...
Key analysis
Impact analysis
Environment
Benefits
- No direct sector effect identified
Risks
- No direct sector effect identified
Economy
Benefits
- Supports data-driven healthcare fiscal planning
Risks
- No direct economic impact identified
Society
Benefits
- Increases transparency regarding sickle cell patient needs
- Supports identification of healthcare coverage gaps
Risks
- Report submission does not guarantee new funding or policy changes
How trustworthy & consequential it is
Source
OpenStates
Confidence
lowlow
Analysis status
OpenStates summary
The submission of this report does not constitute the enactment of new programs or resource allocation for sickle cell treatment
Full bill text is not available
Where it stands
Introduced
CurrentPlaced on file
Committee
UpcomingFloor
UpcomingGovernor
UpcomingEnacted
UpcomingHow it affects your district
Set your location
Add your district to see how this bill may affect your community and who to contact.
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.